The Rising Threat of Antimicrobial Resistance
Clinical labs are on the front lines of the battle against drug-resistant bacteria and other organisms.
Read More
Search Results for: liver disease
ASCP Joins Effort to Spotlight Inequities in Cancer Detection, Treatment Access
ASCP says that current inequities in risk-factor exposure, and in access to screening, early detection, and timely and appropriate treatment and care, must be addressed.
Read More
Thermo Fisher Scientific Introduces Next-Generation Sequencers
The system reads lengths of up to 600 base pairs to drive powerful and cost-effective experiments in multiple areas, including cancer research, inherited disease, and microbial and infectious disease applications.
Read More
FDA Unveils Streamlined Path for the Authorization of Tumor Profiling Tests
FDA has granted market clearance to Memorial Sloan Kettering Cancer Center’s integrated mutation profiling of actionable cancer targets tumor profiling test, an in vitro diagnostic that can identify a greater number of genetic mutations in various cancers than any test previously reviewed by the agency.
Read More
Single Blood Test Screens for Eight Common Cancers
The cancers that the test screens for—cancers of the breast, colorectum, esophagus, liver, lung, ovary, pancreas, and stomach—account for more than 60% of cancer deaths in the United States.
Read More